Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Am J Clin Pathol ; 115(6): 894-8, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11392887

ABSTRACT

Accurate platelet enumeration is critical for optimal treatment of patients with platelet and bleeding disorders, leukemias, and other neoplasias. The majority of automated hematology analyzers count platelets by size differentiation alone, which may result in falsely elevated platelet counts for samples containing interfering particles such as RBC fragments, microcytes, and cell debris. Most analyzers flag questionable platelet counts, necessitating review of results with confirmation by an alternative method, thus increasing the cost of performing platelet counts and delaying results. We studied the effect of a new platelet analysis method, based on measurement of size and refractive index, on the laboratory review rate for platelet counting. We demonstrated that this method yields higher accuracy for platelet counts in samples with interferences, especially for platelet counts less than 50 x 10(3)/microL (< 50 x 10(9)/L). As a result of the 2-dimensional analysis, the review rate for platelet counts was reduced by 65% in our institution, resulting in substantial savings.


Subject(s)
Platelet Count/methods , Blood Platelets/cytology , Cell Size , Costs and Cost Analysis , Humans , Platelet Count/economics , Refractometry , Sensitivity and Specificity
2.
J Immunol ; 164(12): 6221-9, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10843674

ABSTRACT

We have applied bacteriophage display technology to construct and analyze the diversity of an IgG library of >1 x 108 clones from an adult sheep immunized against the hapten atrazine. We have identified eight new VH gene families (VH2-VH9) and five new Vkappa gene families (VkappaV-VkappaIX). The heavy and kappa light chain variable region gene loci were found to be far more diverse than previously thought.


Subject(s)
Antibody Diversity/genetics , Gene Library , Sheep/genetics , Sheep/immunology , Animals , Atrazine/immunology , Base Sequence , Coliphages/genetics , Coliphages/immunology , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Gene Rearrangement, B-Lymphocyte, Light Chain , Haptens/immunology , Immunoglobulin Heavy Chains/genetics , Immunoglobulin J-Chains/genetics , Immunoglobulin Variable Region/genetics , Immunoglobulin kappa-Chains/genetics , Immunoglobulin lambda-Chains/genetics , Molecular Sequence Data
3.
J Appl Microbiol ; 87(3): 410-7, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10540244

ABSTRACT

Single-chain antibody fragments (scAb), specific for the chlorophenoxy acid herbicide mecoprop, have been expressed and purified from the bacterium Escherichia coli. Co-expression with the colE1-compatible, arabinose-inducible, skp expression vector pHELP1 prevented bacterial lysis and significantly increased both total and functional expression yield. The periplasmic protein, SKP, may have a role as a generic detoxification protein. Surface plasmon resonance (BIAcore 2000) analysis confirmed that the purified scAb retained similar binding kinetics to the monoclonal antibody (Mab) from which it was cloned. In competition ELISA, the bacterial scAb showed the same specificity for mecoprop and a related herbicide, MCPA, as the Mab but an increase in sensitivity for free antigen in all ELISA formats. Bacterially expressed antibody fragments provide a simple, sensitive and cost-effective alternative to the traditional production of diagnostic Mabs via tissue culture.


Subject(s)
2-Methyl-4-chlorophenoxyacetic Acid/analogs & derivatives , Environmental Pollutants/analysis , Enzyme-Linked Immunosorbent Assay/methods , Herbicides/analysis , Immunoglobulin Fragments/biosynthesis , 2-Methyl-4-chlorophenoxyacetic Acid/analysis , 2-Methyl-4-chlorophenoxyacetic Acid/immunology , Antibodies/genetics , Antibody Specificity , Binding, Competitive , Environmental Pollutants/immunology , Escherichia coli/genetics , Herbicides/immunology , Immunoglobulin Fragments/genetics , Protein Binding , Recombinant Proteins/biosynthesis , Sensitivity and Specificity
4.
Aust Health Rev ; 22(3): 44-55, 1999.
Article in English | MEDLINE | ID: mdl-10662232

ABSTRACT

This article explores why patients sue their health care providers. Following an extensive literature review, it identifies 'sue' motivators and then examines the legal basis of medical litigation by reviewing contemporary case law. Armed with the 'sue' motivators and having considered the types of claims brought against health care providers, the article focuses upon what health care providers may do to minimise litigation. It recommends specific provocative measures, which are based upon satisfying a myriad of patient needs through consenting practices, and early recognition and resolution of patient issues by providers.


Subject(s)
Informed Consent , Malpractice/legislation & jurisprudence , Patient Acceptance of Health Care/psychology , Physician-Patient Relations , Australia , Communication , Diagnostic Errors , Humans , Medical Errors , Motivation , Patient Acceptance of Health Care/statistics & numerical data , Refusal to Treat
5.
Hum Antibodies Hybridomas ; 2(1): 11-5, 1991 Jan.
Article in English | MEDLINE | ID: mdl-1873494

ABSTRACT

Human monoclonal antibodies have been produced from lymphocytes of an acute-onset insulin-dependent diabetic patient. Peripheral blood lymphocytes were hybridized with a fusion partner HMY-1320. Initial screening of human immunoglobulin secretion was made by a nitrocellulose dot blot assay. Ten stable cell lines of novel type, secreting human immunoglobulin, were obtained. These cell lines have been maintained in continuous culture over 6 months and cryopreserved in liquid nitrogen for 14 months. Human monoclonal antibodies of IgG and IgM class have been produced and are secreted at a rate of 150-650 ng/ml/10(6) cells/day. Monoclonal antibodies were tested for histological staining against a variety of endocrine and non-endocrine tissues. One monoclonal antibody, LT1E12, demonstrates a staining pattern in human, rat, and mouse tissues, similar to that of mitochondrial antibodies. Another antibody, LT3C4, demonstrates weak staining of smooth muscle in rat and mouse kidney sections. Neither specificities were detected in the diabetic patient's serum. The variety of immune tissue specificities obtained in this study demonstrates the potential value of human monoclonal antibodies as probes to analyze the complexity of autoimmunity in diabetes mellitus.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Autoantibodies/biosynthesis , Diabetes Mellitus, Type 1/immunology , Cell Line , Humans , Immunoglobulin G/biosynthesis , Immunoglobulin G/metabolism , Immunoglobulin M/biosynthesis , Immunoglobulin M/metabolism
6.
Br J Haematol ; 66(1): 27-36, 1987 May.
Article in English | MEDLINE | ID: mdl-3593655

ABSTRACT

Peripheral blood samples from 118 patients with acute leukaemia (68 untreated; 50 treated) were measured with the Technicon H-6000 automated haematology analyser. This instrument provides, in addition to measurements of the classical haematology parameters (i.e. cell counts, haemoglobin concentration, etc.), a differential count on 10(4) WBC effected by means of flow cytochemistry (peroxidase content) and volume (light scatter) discrimination. Disregarding RBC and platelet counts and their volume distribution profiles, the most important diagnostic parameters for leukaemic disease were the WBC count, the WBC differential count, and the proportions of large unstained cells (LUC) and high peroxidase (HPX) cells obtained by the automated differential count as well as the mean value of the WBC peroxidase content distribution (MPA). Granulocytic leukaemias had lower MPA than normal and lymphocytic leukaemias had MPA values above normal. M1 leukaemias were also characterized by large proportions of LUC and low fractions of HPX, while M2 leukaemias showed low LUC with high HPX. M3 leukaemias had low LUC and very high HPX. M4 leukaemias had large LUC and 'monocytic' components and a modest fraction of HPX. M5 leukaemias had very large numbers of LUC, 'monocytes' and 'lymphocytes' and a normal HPX. For M1 leukaemia, the presence of less than 7% LUC following induction treatment was related to morphological changes of normal cells induced by chemotherapy while LUC above 10% usually indicated unsuccessful induction associated with the presence of residual blasts. If treatment was successful, M2 and M3 leukaemias characteristically decreased their HPX population. All M4 leukaemias studied by us failed to enter remission and continued to display high proportions of HPX and LUC. Similarly, most M5 leukaemias had a poor response to treatment and always showed a very high proportion of LUC. Untreated lymphocytic leukaemias demonstrated high LUC, normal HPX and a high proportion of 'lymphocytes'. Hairy cell leukaemias showed almost equal proportions of 'lymphocytes' and LUC. Successful chemotherapy of all lymphoid leukaemia entities was associated with rapid decreases in LUC, slower decrements of 'lymphocytes' and moderate and transient increments in HPX. Thus, flow cytochemistry can assist not only in the segregation of acute leukaemias along with FAB classification with nonmorphologic criteria, but also in the follow up of patients with these diseases.


Subject(s)
Flow Cytometry/instrumentation , Leukemia/blood , Leukocytes/pathology , Acute Disease , Histocytochemistry , Humans , Leukemia/drug therapy , Leukocyte Count
7.
J Histochem Cytochem ; 32(12): 1262-4, 1984 Dec.
Article in English | MEDLINE | ID: mdl-6438227

ABSTRACT

Human muscle sections were examined for the presence of carbonic anhydrase using fluorescent second antibody and antisera specific for the three isozymes, carbonic anhydrase I (CAI), carbonic anhydrase II (CAII), and carbonic anhydrase (CAIII). CAIII was present in all fibers, CAII only in the connective tissue, and CAI showed a weak association with the sarcolemma.


Subject(s)
Carbonic Anhydrases/analysis , Isoenzymes/analysis , Muscles/enzymology , Fluorescent Antibody Technique , Histocytochemistry , Humans , Muscles/ultrastructure , Sarcolemma/enzymology , Sarcolemma/ultrastructure
8.
J Clin Pathol ; 37(10): 1172-6, 1984 Oct.
Article in English | MEDLINE | ID: mdl-6386892

ABSTRACT

An improved, rapid, and sensitive (to autoradiographic levels) method for the quantification of IgG bands from cerebrospinal fluid is presented. The principle of an internal standard is employed using the discrete bands of a paraprotein to correct for any run to run variability in the enzyme detection system which is linked to the immunoassay of immobilised antigen.


Subject(s)
Immunoglobulin G/cerebrospinal fluid , Paraproteins/cerebrospinal fluid , Electrophoresis, Agar Gel , Humans , Immunoenzyme Techniques , Isoelectric Focusing/methods
9.
Biosci Rep ; 4(6): 505-10, 1984 Jun.
Article in English | MEDLINE | ID: mdl-6380610

ABSTRACT

A new method for detecting viral antibodies in cerebrospinal fluid is described. The technique has many advantages over previously published methods in that it is highly sensitive eliminating the need to concentrate the CSF, takes 5 h to complete, avoids the use of radionucleides, and most importantly circumvents problems associated with prozone effects which occur in immunoprecipitation reaction since the viral antigen is immobilized on nitrocellulose membranes.


Subject(s)
Antibodies, Viral/cerebrospinal fluid , Cerebrospinal Fluid/immunology , Humans , Immunoglobulin G/cerebrospinal fluid , Immunologic Techniques , Isoelectric Point
SELECTION OF CITATIONS
SEARCH DETAIL
...